Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Pintex Pharmaceuticals claims Pin1 inhibitors and their use in cancer therapy

Oct. 16, 2003

Selective erbB2 kinase inhibitor CP-654577 inhibits growth of human breast cancer

Oct. 15, 2003

FDA accepts Erbitux BLA for filing

Oct. 14, 2003

Novel VEGFR2 modulators prepared and tested at Pfizer

Oct. 14, 2003

New polyamine is effective and well tolerated in human prostate xenograft models

Oct. 14, 2003

Safety and pharmacokinetics of single-dose oral glutamine in pediatric oncology patients

Oct. 13, 2003

Millennium commences phase I/II study of MLN-2704 in prostate cancer

Oct. 13, 2003

Thymitaq designated orphan drug in E.U. for liver cancer

Oct. 13, 2003

U. of Tennessee team claims novel androgen receptor antagonists

Oct. 13, 2003

GSK antiangiogenic Tie-2 and/or VEGFR2 inhibitors covered by patent

Oct. 13, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 24, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 21, 2026
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
At AACR: Epigenetic fingerprints in metastases track tumor origin
BioWorld
When a tumor migrates and colonizes another tissue or organ, it can be identified as a metastasis, but its origin is not always clear. Now, a study based on...
AACR 2026: The age of agentic AI in oncology
BioWorld Science
New Approach Methodologies (NAMs) for drug development are transforming biomedical research by replacing or complementing animal models. More than 90% of...